A triglyceride-raising APOA5 genetic variant is negatively associated with obesity and BMI in the Chinese population

Obesity

Volumn 18, Issue 10, 2010, Pages 1964-1968

  Wu, Cho Kai ^a,b   Chang, Yi Cheng ^a   Hua, Shih Che ^c   Wu, Hon Yen ^a   Lee, Wei Jei ^d   Chiang, Fu Tien ^a   Hwang, Juey Jen ^a   Lien, Wen Pin ^a   Chuang, Lee Ming ^a,b  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c CHIA YI CHRISTIAN HOSPITAL   (Taiwan)

^d MIN SHENG GENERAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

APOA5 PROTEIN, HUMAN; APOLIPOPROTEIN A; TRIACYLGLYCEROL;

ADULT; AGED; ALLELE; ARTICLE; ASIAN; BLOOD; BODY MASS; ETHNOLOGY; FEMALE; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; HUMAN; MALE; MIDDLE AGED; OBESITY; RISK; RISK FACTOR;

ADULT; AGED; ALLELES; APOLIPOPROTEINS A; ASIAN CONTINENTAL ANCESTRY GROUP; BODY MASS INDEX; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; OBESITY; ODDS RATIO; POLYMORPHISM, GENETIC; RISK FACTORS; TRIGLYCERIDES; YOUNG ADULT;

EID: 77957137059     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2010.10     Document Type: Article

References (31)

1. Cullen P. Evidence that triglycerides are an independent coronary heart disease risk factor. Am J Cardiol 2000;86:943-949.
2. Pennacchio LA, Olivier M, Hubacek JA, et al. An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing. Science 2001;294:169-173.
3. Fruchart-Najib J, Baugé E, Niculescu LS, et al. Mechanism of triglyceride lowering in mice expressing human apolipoprotein A5. Biochem Biophys Res Commun 2004;319:397-404.
4. Merkel M, Loeffler B, Kluger M, et al. Apolipoprotein AV accelerates plasma hydrolysis of triglyceride-rich lipoproteins by interaction with proteoglycan-bound lipoprotein lipase. J Biol Chem 2005;280: 21553-21560.
5. Schaap FG, Rensen PC, Voshol PJ, et al. ApoAV reduces plasma triglycerides by inhibiting very low density lipoprotein-triglyceride (VLDL-TG) production and stimulating lipoprotein lipase-mediated VLDL-TG hydrolysis. J Biol Chem 2004;279:27941-27947.
6. Lookene A, Beckstead JA, Nilsson S, Olivecrona G, Ryan RO. Apolipoprotein A-V-heparin interactions: implications for plasma lipoprotein metabolism. J Biol Chem 2005;280:25383-25387.
7. Pamir N, McMillen TS, Li YI, et al. Overexpression of apolipoprotein A5 in mice is not protective against body weight gain and aberrant glucose homeostasis. Metab Clin Exp 2009;58:560-567.
8. Kluger M, Heeren J, Merkel M. Apoprotein A-V: an important regulator of triglyceride metabolism. J Inherit Metab Dis 2008; e-pub ahead of print 14 April 2008.
9. Kao JT, Wen HC, Chien KL, Hsu HC, Lin SW. A novel genetic variant in the apolipoprotein A5 gene is associated with hypertriglyceridemia. Hum Mol Genet 2003;12:2533-2539.
10. Tang Y, Sun P, Guo D, et al. A genetic variant c.553G > T in the apolipoprotein A5 gene is associated with an increased risk of coronary artery disease and altered triglyceride levels in a Chinese population. Atherosclerosis 2006;185:433-437.
11. Zhai G, Wen P, Guo L, Chen L. Association of APOA5 c.553G>T polymorphism with type 2 diabetes mellitus in a Chinese population. Clin Chem Lab Med 2006;44:1313-1316.
12. Pullinger CR, Aouizerat BE, Movsesyan I, et al. An apolipoprotein A-V gene SNP is associated with marked hypertriglyceridemia among Asian-American patients. J Lipid Res 2008;49:1846-1854.
13. Jiang YD, Yen CJ, Chou WL, et al. Interaction of the G182C polymorphism in the APOA5 gene and fasting plasma glucose on plasma triglycerides in type 2 diabetic subjects. Diabet Med 2005;22:1690-1695.
14. Chien KL, Fang WH, Wen HC, et al. APOA1/C3/A5 haplotype and risk of hypertriglyceridemia in Taiwanese. Clin Chim Acta 2008;390:56-62.
15. Chien KL, Chen MF, Hsu HC, et al. Genetic association study of APOA1/C3/ A4/A5 gene cluster and haplotypes on triglyceride and HDL cholesterol in a community-based population. Clin Chim Acta 2008;388:78-83.
16. Deurenberg P, Weststrate JA, Seidell JC. Body mass index as a measure of body fatness: age- and sex-specific prediction formulas. Br J Nutr 1991;65:105-114.
17. Wu CK, Tsai CT, Chang YC, et al. Genetic polymorphisms of the angiotensin II type 1 receptor gene and diastolic heart failure. J Hypertens 2009;27:502-507.
18. Purcell S, Cherny SS, Sham PC. Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits. Bioinformatics 2003;19:149-150.
19. Bei-Fan Z. Predictive values of body mass index and waist circumference for risk factors of certain related diseases in Chinese adults: study on optimal cut-off points of body mass index and waist circumference in Chinese adults. Asia Pac J Clin Nutr 2002;11 Suppl 8:S685-S693.
20. Willer CJ, Sanna S, Jackson AU, et al. Newly identified loci that influence lipid concentrations and risk of coronary artery disease. Nat Genet 2008;40:161-169.
21. Bi N, Yan SK, Li GP, Yin ZN, Chen BS. A single nucleotide polymorphism -1131T>C in the apolipoprotein A5 gene is associated with an increased risk of coronary artery disease and alters triglyceride metabolism in Chinese. Mol Genet Metab 2004;83:280-286.
22. Lai CQ, Tai ES, Tan CE, et al. The APOA5 locus is a strong determinant of plasma triglyceride concentrations across ethnic groups in Singapore. J Lipid Res 2003;44:2365-2373.
23. Baum L, Tomlinson B, Thomas GN. APOA5-1131T>C polymorphism is associated with triglyceride levels in Chinese men. Clin Genet 2003;63: 377-379.
24. Kathiresan S, Willer CJ, Peloso GM, et al. Common variants at 30 loci contribute to polygenic dyslipidemia. Nat Genet 2009;41:56-65.
25. International HapMap Consortium. A haplotype map of the human genome. Nature 2005; 437:1299-1320.
26. Kathiresan S, Melander O, Guiducci C, et al. Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans. Nat Genet 2008; 40:189-197.
27. Corella D, Lai CQ, Demissie S, et al. APOA5 gene variation modulates the effects of dietary fat intake on body mass index and obesity risk in the Framingham Heart Study. J Mol Med 2007;85:119-128.
28. Aberle J, Evans D, Beil FU, Seedorf U. A polymorphism in the apolipoprotein A5 gene is associated with weight loss after short-term diet. Clin Genet 2005;68:152-154.
29. Matsunaga A, Arishima H, Niimura H, et al. Strong linkage disequilibrium and association of -1131T>C and c.553G>T polymorphisms of the apolipoprotein A5 gene with hypertriglyceridemia in a Japanese population. Circ J 2007;71:746-752.
30. Rensen PC, van Dijk KW, Havekes LM. Apolipoprotein AV: low concentration, high impact. Arterioscler Thromb Vasc Biol 2005;25: 2445-2447.
31. Dorfmeister B, Zeng WW, Dichlberger A, et al. Effects of six APOA5 variants, identified in patients with severe hypertriglyceridemia, on in vitro lipoprotein lipase activity and receptor binding. Arterioscler Thromb Vasc Biol 2008;28:1866-1871.